By Joe Hoppe
Reckitt Benckiser Group PLC said Tuesday that its third-quarter revenue rose on a like-for-like basis but slipped on a reported basis, and raised its full-year revenue guidance.
The consumer-goods company, which houses Dettol, Harpic and Durex among its brands, said quarterly revenue fell 6.8% on year on a reported basis to 3.28 billion pounds ($4.52 billion). Like-for-like revenue growth was 3.3%, Reckitt said.
The company said its like-for-like broad-based growth and encouraging start to the cold and flu season was offset by mergers and acquisition expenses, and adverse foreign exchange movements.
Year-to-date revenue stood at GBP9.87 billion, up 3.6% on a like-for-like basis but down 5.3% on a reported basis compared with the year-earlier period, it added.
The company said that all of its geographic regions reported growth, and nine of its 10 largest brands sales are up by double-digit percentages on a two-year basis.
"Despite significant cost pressures, the benefits of our pricing actions, mix and productivity program, mean our margin guidance is unchanged, and we remain confident in our medium-term outlook," Chief Executive Laxman Narasimhan said.
Reckitt Benckiser said it now expects full-year like-for-like net revenue to increase by around 1% to 3% on year, on the back of its stronger-than-expected performance.
Write to Joe Hoppe at firstname.lastname@example.org